KTTA   $4.29  7.52% Market Closed

Pasithea Therapeutics Corp
Total Cash 7.97M
totalCashPerShare 7.631
EBITDA -16.27M
Total Debt 0.00
quickRatio 5.712
currentRatio 6.196
Total Revenue
debtToEquity
Revenue/Share
ROA -0.37903
ROE -0.6325
grossProfits
freeCashflow -9.02M
operatingCashflow -14.92M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -3.84M
forwardPE
floatShares 802.46K
sharesOutstanding 1.04M
sharesShort 171.29K
sharesShortPriorMonth 4.25K
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.23%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.06%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 15.492
Price To Book help_outline 0.26
earningsQuarterlyGrowth
netIncomeToCommon -16.37M
trailingEps -14.79%
forwardEps -0.71%
enterpriseToEbitda 0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2022
institutionsCount 7
lastUpdated Oct. 17, 2024, 12:12 a.m.